Reproducibility studies performed with adequate control materials are pre- requisites for the safe introduction of proteomic techniques in clinical laboratory practice. Current limitations and open questions regarding clinical proteomics, therefore reflect a lack of appreciation of the many steps, such as evaluation of pre-analytical, intra-analytical and post-analytical issues, inter-laboratory performance, standardization and quality control that are needed to move from method discovery to clinical practice.